ICU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SeaStar Medical Holding Corp (ICU) does not present a strong buy opportunity for a beginner, long-term investor at this time. While the analyst rating is positive with a raised price target, the technical indicators and lack of significant trading trends, news, or proprietary trading signals suggest a neutral stance. The stock's recent price movement and lack of strong catalysts do not align with the user's preference for immediate, clear opportunities.
The MACD is positive and expanding, suggesting mild bullish momentum. However, the RSI is neutral at 53.177, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key resistance levels are at 3.317 and 3.519, while support levels are at 2.662 and 2.46. Overall, the technical indicators do not strongly support a buy signal.
Analyst Anthony Vendetti raised the price target to $8 from $6 and maintained a Buy rating. Q1 revenue, gross margin, and gap loss per share were above estimates. Revenue estimates for 2026 and 2027 were increased.
Higher expected operating expenses leading to a widened loss per share outlook. Bearish moving averages and lack of significant trading trends from hedge funds or insiders. No recent news or Congress trading data to act as a catalyst.
No financial data available for analysis.
Maxim analyst raised the price target to $8 from $6 and maintained a Buy rating. Positive Q1 performance was noted, but concerns about higher operating expenses were also highlighted.
